Fig. 7. Simultaneous treatment of 2-APB and BZM do not cause significant liver toxicity.

Twenty-four mice were randomly divided into four groups as indicated and were treated following the treatment regimen in Supplementary figure 2. a Representative images of liver and weights. b Serum alanine transaminase (ALT), aspartate transaminase (AST), and alkaline phosphatase (AlkP) levels of drug-treated mice. All data are mean ± SEM from 6 mice (3 males and 3 females) per treatment group. *P < 0.05, **P ≤ 0.01, ***P ≤ 0.001, one-way ANOVA analysis